2014
DOI: 10.1245/s10434-014-4248-7
|View full text |Cite
|
Sign up to set email alerts
|

Persistent Postmastectomy Pain and Pain-Related Physical and Emotional Functioning With and Without a Continuous Paravertebral Nerve Block: A Prospective 1-Year Follow-Up Assessment of a Randomized, Triple-Masked, Placebo-Controlled Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
67
2

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 84 publications
(69 citation statements)
references
References 59 publications
0
67
2
Order By: Relevance
“…It remains unknown if the two groups had little pain simply due to non-intervention factors (e.g., surgical technique), or because both treatments decreased chronic pain equivalently. Regardless of the underlying etiology, this study's negative findings do not contradict the three positive RCTs demonstrating that a continuous paravertebral block reduces both the incidence and intensity of persistent post-surgical pain [103,110,200].…”
Section: Persistent Post-surgical (Chronic) Painmentioning
confidence: 45%
See 1 more Smart Citation
“…It remains unknown if the two groups had little pain simply due to non-intervention factors (e.g., surgical technique), or because both treatments decreased chronic pain equivalently. Regardless of the underlying etiology, this study's negative findings do not contradict the three positive RCTs demonstrating that a continuous paravertebral block reduces both the incidence and intensity of persistent post-surgical pain [103,110,200].…”
Section: Persistent Post-surgical (Chronic) Painmentioning
confidence: 45%
“…One RCT provided evidence that a singleinjection paravertebral block with bupivacaine decreases pain scores and opioid requirements within the first 24 postoperative hours [16], as well as the incidence of subsequent severe pain after 1, 6, and 12 months [110]. And three RCTs reported that a 48-72-hour continuous paravertebral nerve block decreased pain (and in some cases pain-related emotional and physical disability) both during the local anesthetic perineural infusion as well as 2.5, 6, and 12 months following surgery [103,110,200]. A single RCT comparing single-injection paravertebral nerve blocks and wound infiltration failed to detect a difference between treatments at 12 months, and unfortunately did not report any pain data prior to the 12-month time point [201].…”
Section: Persistent Post-surgical (Chronic) Painmentioning
confidence: 99%
“…84,90 In addition, 4 studies (only 2 of which were double-blind) demonstrated an improvement in pain incidence or characteristics at 1 to 12 postoperative months. 9,76,101,103 In summary, the literature supports PVB as an effective perioperative analgesic technique for breast surgery. Paravertebral block can also provide surgical anesthesia and may decrease nausea and vomiting, hospital stay, and chronic postsurgical pain.…”
Section: Paravertebral Blockmentioning
confidence: 96%
“…They suggested that their study does not support the routine use of continuous paravertebral catheter anesthesia in patients undergoing operative treatment for breast cancer [8]. Conversely, in 2014, Ilfeld et al [4] conducted a similar study and concluded that adding a multiple-day; continuous ropivacaine infusion to a single-injection ropivacaine paravertebral nerve block may result in a lower incidence of pain as well as pain-related physical and emotional dysfunction 1 year after mastectomy.…”
Section: Single Injection or Infusion For Breast Surgerymentioning
confidence: 99%
“…They concluded that even though there was no significant difference in the incidence or relative risk of chronic pain at 3 and 6 months when TPVB was used in conjunction with GA, nevertheless, patients who received TPVBs reported less severe chronic pain, exhibited fewer symptoms and signs of chronic pain, and also experience better physical and mental health-related quality of life [3]. Ilfeld et al [4] also reported that only 14% of those who received TPVBs developed chronic pain as compared with 47% of those who did not.…”
Section: Prevention Of Chronic Painmentioning
confidence: 99%